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ABSTRACT
Cost-effective oligonucleotide genotyping arrays
like the Affymetrix SNP 6.0 are still the predominant
technique to measure DNA copy number variations
(CNVs). However, CNV detection methods for micro-
arrays overestimate both the number and the size of
CNV regions and, consequently, suffer from a high
false discovery rate (FDR). A high FDR means that
many CNVs are wrongly detected and therefore not
associated with a disease in a clinical study, though
correction for multiple testing takes them into
account and thereby decreases the study’s discov-
ery power. For controlling the FDR, we propose a
probabilistic latent variable model, ‘cn.FARMS’,
which is optimized by a Bayesian maximum a pos-
teriori approach. cn.FARMS controls the FDR
through the information gain of the posterior over
the prior. The prior represents the null hypothesis
of copy number 2 for all samples from which the
posterior can only deviate by strong and consistent
signals in the data. On HapMap data, cn.FARMS
clearly outperformed the two most prevalent
methods with respect to sensitivity and FDR. The
software cn.FARMS is publicly available as a R
package at http://www.bioinf.jku.at/software/
cnfarms/cnfarms.html.
INTRODUCTION
Copy number varations (CNVs) are one or more kilobases
long DNA regions with varying copy numbers between
individuals (1). In biology and population genetics,
CNVs help to understand the origin and evolution of
genomes (1–3). In medicine, associations between CNVs
and diseases were discovered, e.g. for systemic auto-
immunity (4), HIV (5), Crohn’s disease and type 1
diabetes (6), type 2 diabetes (7–9), malaria, breast and
prostate cancer, multiple sclerosis and bipolar disorder
(10). In most CNV studies, DNA oligonucleotide arrays
like the Affymetrix Genome-wide SNP 6.0 arrays are
applied. These arrays possess both high coverage and
high resolution through their large number of genetic
markers (the probes). They are able to detect CNVs in
formalin-ﬁxed, parafﬁn-embedded (FFPE) tissue samples
which were stored decades ago (11,12). FFPE samples are
attractive because instead of designing new studies,
existing biobanks can be utilized, though the measure-
ments are more noisy.
If analyzing CNV data from microarrays, researchers
face the serious problem of high false discovery rates
(FDRs), i.e. the fraction of wrongly detected or too
large CNV regions. CNVs are wrongly detected because
of random probe variations through measurement noise.
Current array techniques strive steadily to increase the
number of probes in order to obtain higher coverage
and higher resolution. However, this coverage is traded
off against more false discoveries, which increase propor-
tional to the number of probes. Each falsely discovered
CNV region may give a false hint for population geneti-
cists or may generate a spurious correlation with a disease
and, therefore, misguides the medical expert. More ser-
iously, a high FDR at CNV detection decreases the dis-
covery power of studies and the signiﬁcance of discoveries
after correction for multiple testing. Falsely discovered
CNVs are not associated with diseases, though correction
for multiple testing takes them into account and reduces
the discovery power of the study. Therefore, FDR control
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avoid that the advantage of higher coverage is counter-
acted by correction for multiple testing. However, current
CNV analysis methods do not control the FDR, as Baross
et al. (13) write ‘The frequency of false positive deletions
was substantial’ with different methods like dChip (14)
and CNAG (15). We introduce cn.FARMS for
array-based CNV analysis which is designed to control
the FDR while ensuring high sensitivity.
Previous array-based CNV analysis methods
We assume that the DNA is ﬁrst cut by enzymes into
fragments which are then ampliﬁed by PCR. The PCR
products are then mechanically fragmented into smaller
pieces before being put on the array. Each CNV region
is broken by enzymes into several DNA fragments each of
which is targeted by several probes. This gives a copy
number hierarchy probes-fragment-region which is
depicted in Figure 1. The more copies of the region
exist, the more fragment copies exist, the higher are the
probe intensities.
As visualized in Figure 2, copy number analysis is,
in principle, a three-step pipeline: (i) normalization,
(ii) probe-level modeling and (iii) segmentation. We
introduce this pipeline to describe previous methods in
the following and to describe our cn.FARMS method in
section ‘MATERIALS AND METHODS’ (note, that
cn.FARMS neither does segmentation nor integer copy
number estimation).
Normalization. Normalization is performed at two levels.
It has as ‘input’ the raw probe intensity values and as
‘output’ intensity values at chromosome locations which
are leveled between arrays and are allele independent. At
the ‘ﬁrst level’, normalization methods remove technical
variations between arrays arising from differences in
sample preparation or labeling, array production (e.g.
batch effects) or scanning differences. The goal of the
ﬁrst level is to correct for array-wide effects. At the
‘second level’, alleles are combined to one intensity value
at a chromosome location. Optional correction for
cross-hybridization between allele A and allele B probes
is performed. Cross-hybridization arise due to close
sequence similarity between the probes of different
alleles, therefore a probe of one allele picks up a signal
of the other allele. The optional corrections for differences
in PCR yield can be performed at this step or after
‘single-locus modeling’ (see below). After normalization,
arrays have comparable, allele-independent probe inten-
sity values, which measure the copy number of a speciﬁc
target fragment or DNA probe site.
Modeling. Modeling is also performed at two levels. The
‘input’ is the probe intensity values which independently
measure the copy number of a speciﬁc target fragment or
DNA probe locus. The ‘output’ is an estimate for the
region copy number. At the ‘ﬁrst level’, ‘single-locus
modeling’, the probes which measure the same fragment
are combined to a raw fragment copy number (‘raw’
means that the copy number is still a continuous value;
Figure 1). An optional intermediate level corrects for the
fragment length and sequence features like the GC content
to make raw fragment copy numbers comparable along
the chromosome. Nannya et al. (15) suggested considering
fragment characteristics like sequence patterns and the
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Figure 1. The copy number hierarchy probes-fragment-region.
Fragment copy numbers serve as meta-probes used for ‘multi-loci
modeling’ which yields region copy numbers. Inner boxes: the probes
which target a fragment (often at a SNP position) are summarized to a
raw copy number of this fragment. Note, that instead of fragments a
DNA probe loci can be summarized. Outer box: the raw fragment copy
numbers are the meta-probes for a DNA region and are summarized to
a raw region copy number.
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Figure 2. Copy number analysis for (Affymetrix) DNA genotyping arrays as a three-step pipeline: (i) normalization, (ii) modeling and (iii) segmen-
tation. Modeling is divided into ‘single-locus modeling’ and ‘multi-loci modeling’ with ‘fragment length correction’ as an optional intermediate step.
As described in subsection ‘cn.FARMS: FARMS for CNV Detection’, cn.FARMS’ pipeline is as follows: normalization by sparse overcomplete
representation, single-locus modeling by FARMS, fragment length correction and multi-loci modeling by FARMS.
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example, PCR is usually less efﬁcient for longer fragments,
which lead to fewer copies to hybridize and result in
weaker probe intensities. At the ‘second level’, ‘multi-loci
modeling’, the raw copy numbers of neighboring frag-
ments or neighboring DNA probe loci are combined to
a ‘meta-probe set’ which targets a DNA region. Raw
fragment copy numbers or DNA probe loci in a region
now serve as probes themselves which measure the
region’s copy number (Figure 1). Multi-loci modeling con-
siderably reduces the FDRs, because raw copy numbers
of neighboring fragments or neighboring DNA probe
loci must agree to each other on the copy number,
which reduces the likelihood of a discovery by chance.
However, low FDR is traded against high resolution by
the window size for multi-loci modeling, i.e. by how many
raw copy numbers of neighboring fragments or neighbor-
ing DNA probe loci are combined.
Segmentation. Segmentation is also performed at two
levels. It has as ‘input’ the continuous raw copy
numbers and as ‘output’ integer copy numbers for
segments. At the ‘ﬁrst level’, segmentation groups
together adjacent raw copy numbers with similar intensity
values. At the ‘second level’, integer copy numbers are
assigned to the regions. Neighboring regions are separated
by breakpoints which indicate a change in the copy
number (16). Note, that this step overlaps with the
previous modeling step because in both steps single loci
can be combined to regions. For example, hidden Markov
models automatically assign integer copy numbers (the
hidden states) and segment the DNA by runs of the
same hidden state.
Using this pipeline, we next categorize existing methods
for analyzing copy number variations on microarray data:
(i) the ﬁrst CNV analysis method has been supplied by
Affymetrix with the hardware. It is called ‘Chromosome
Copy Number Analysis Tool’ (CNAT) where version 1.0
appeared as early as 2004 but now version 4.0 (17) can be
used. (a) Normalization is performed at the ﬁrst level by
quantile normalization (18). The second level is skipped
because the alleles are separately modeled. (b) Modeling
uses robust multichip average [RMA (18–20)] for
allele-speciﬁc single-locus modeling. RMA is an additive
model ﬁtted by median polish. (ii) Following CNAT,
the ‘DNA-Chip Analyzer’ (dChip) software for
transcriptomic data was modiﬁed to allow for CNV
analysis (21). (a) Normalization at the ﬁrst level is based
on the invariant set method which corresponds to normal-
ize the arrays based on probes with known copy numbers.
At the second level, allele A and B probe intensities are
added. (b) Modeling is based on model-based expression
index [MBEI (14)] for single-locus modeling. MBEI itera-
tively estimates a linear model that is the product of a raw
copy number and a probe pattern by least squares. (c)
Segmentation is either performed by computing the
median over a region or by a hidden Markov model.
(iii) One of the early CNV analysis methods is ‘Copy
Number Analyser for GeneChip’ [CNAG (15)]. (a)
Normalization starts with the second level, namely to
remove allele-speciﬁc probe signals by adding allele
A and B probes to give allele-independent fragment
probe intensities per array. Next the arrays are normalized
to have the same mean signal intensity for all autosomal
probes which make fragment probes comparable between
arrays. (b) Modeling skips single-locus modeling and
directly corrects for fragment length and for the GC
content. Both corrections are realized by a quadratic re-
gression which predicts intensities based on GC content
and fragment length. (iv) A CNV analysis software, which
is broadly used, is Birdsuite’s Birdseye (22).
(a) Normalization is performed at the ﬁrst level by
quantile normalization like with CNAT. Normalization
at the second level is realized by SNP genotyping
through the Birdseed method via a mixture clustering.
(b) Modeling and (c) Segmentation are performed
together at the multi-loci level. The hidden states of a
hidden Markov model (HMM) give the copy numbers
and its outputs are the probe intensities for the estimated
genotype. The HMM reuses the mixture distributions
from Birdseed as emission probabilities for copy number
2 while emission probabilities for copy number 0 and 1 are
estimated on the X chromosome using the sex informa-
tion. (v) Most recently ‘Copy-number estimation using
Robust Multichip Analysis’ [CRMA (23), CRMA_v2
(24)] has been proposed as an extension of the RMA
model. (a) Normalization at the ﬁrst and second level
are combined by allelic cross-hybridization correction
(ACC). ACC performs allele correction array-wise in the
2D space of the allele A and allele B intensity. A cone is
ﬁtted to the data such that one border of the cone is a
regression line for the AA genotype and the other border
for the BB genotype. Similar to the left and right line in
Figure 3. The cone ﬁtting allows estimating how much
allele A cross-hybridizes at the allele B probe and vice
versa. Genotype AA (allele A only) should lead to
minimal intensity at the allele B probe and genotype BB
(allele B only) to minimal intensity at allele A probe. The
genotype AB is assumed to have the same cross-
hybridization characteristics as genotypes AA and BB.
Finally, the probes are normalized by scaling them to a
pre-speciﬁed mean intensity value. (b) Modeling for
single-locus raw copy numbers is performed via RMA.
Then CRMA corrects for the GC pattern and for the
fragment length where the former showed little effect
and is therefore not recommended by the authors (23).
Most CNV analysis methods allow using an arbitrary seg-
mentation algorithm [for an overview see Ref. (25)].
Popular is the Gain and Loss Analysis of DNA
(GLAD) model which is a local constant Gaussian regres-
sion model (26). Using a weighted maximum likelihood
estimator, GLAD estimates regions with constant copy
numbers. Other methods like CGHMIX (27) estimate
the copy number by a mixture model incorporating
spatial information. Spatial information is also utilized
by segmentation with an HMM like in Birdseye and in
the ‘Segmental Maximum A Posteriori’ approach
[SMAP (28)]. Also ‘PennCNV’ (29) and ‘vanillaICE’ (30)
apply an HMM to integer copy number estimation using
spacial and genotype information.
However, all mentioned methods do not control the
FDR and are prone to high FDRs. We will control the
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MATERIALS AND METHODS
We propose a novel CNV detection method, called
‘cn.FARMS’, which is based on our FARMS [‘factor
analysis for robust microarray summarization’ (31)] algo-
rithm for summarizing probe sets of expression arrays.
Expression array summarization estimates the expression
value of a gene which is basically its mRNA copy number.
The expression value of an mRNA is computed from in-
tensity values of all probes targeting it that is the probe
intensities are summarized. Since 2006, FARMS is the
leading summarization method of the international
‘affycomp’ competition if sensitivity and speciﬁcity are
considered simultaneously. We extend FARMS to
cn.FARMS for detecting CNVs by moving from mRNA
copy numbers to DNA copy numbers.
cn.FARMS: FARMS for CNV detection
cn.FARMS is described by the pipeline depicted in
Figure 2: (i) normalization at the ﬁrst and second level
are combined similar as for CRMA (23). However,
instead of CRMA’s ACC, we propose sparse
overcomplete representation in the 2D space of allele A
and B intensity. Therefore, we do not only estimate the
AA and the BB cross-hybridization like CRMA but also
the AB cross-hybridization. The latter takes into account
that hybridization and cross-hybridization may be differ-
ent for the AB genotype, where for both allele probes
target fragments are available and compete for hybridiza-
tion. After allele correction, we follow CRMA and nor-
malize by scaling the probes to a pre-speciﬁed mean
intensity value. CNV probes which have only one allele
are scaled in the same way. (ii) At the ﬁrst level,
‘single-locus modeling’, raw fragment copy numbers are
estimated by FARMS. The original FARMS was designed
to summarize probes which target the same mRNA. This
can readily be transfered to CNV analysis where FARMS
now summarizes probes which target the same DNA
fragment. Either both strands can be summarized
together or separately where our default is the former.
Following the suggestions in Nannya et al. (15),
cn.FARMS performs GC and fragment length correction.
At the second level, ‘multi-loci modeling’, the raw copy
numbers of neighboring fragments or neighboring DNA
probe loci are combined to a ‘meta-probe set’ which
targets a DNA region. The raw fragment copy numbers
from single-locus modeling are now themselves probes for
a DNA region as depicted in Figure 1. Again, we use
FARMS to summarize metaprobes and to estimate a
raw copy number for the region. This modeling across
samples is novel as previous methods only model along
the chromosome. FARMS supplies an informative/
non-informative (I/NI) call (32,33) which is used to
detect CNVs. Additionally, the I/NI value gives the
signal-to-noise-ratio of the estimated raw copy number.
(iii) Segmentation and estimation of integer copy
numbers is performed by segmentation methods like
those which were mentioned at the end of the
‘Introduction’ section.
In our pipeline, FARMS is used for both single-locus
and multi-loci CNV analysis. The more loci are combined,
the more the FDR is reduced, because more metaprobes
must mutually agree on the region’s copy number. The
window size for multi-loci modeling is a hyperparameter
which trades off low FDR against high resolution. We
recommend a window size of 5 as default, 3 for high reso-
lution and 10 for low FDR. Alternatively to a ﬁxed
number of CNV or SNP sites, the cn.FARMS software
allows deﬁning a window in terms of base pairs. In this
case, multi-loci modeling may use a different number of
metaprobes at different DNA locations, in particular for
less than two metaprobes multi-loci modeling is skipped.
Note, however, that controlling the FDR is more difﬁcult
because a minimal number of metaprobes cannot be
assured for each window and modeling with few
metaprobes is prone to false discoveries. cn.FARMS
introduces at several steps novel algorithms into the
CNV detection pipeline. First, at the normalization
step sparse overcomplete representation is used for allele
correction. Second, FARMS is used for ‘single-locus
modeling’. Third, FARMS is used for ‘multi-loci
modeling’ which supplies the raw region copy numbers.
Fourth, and most importantly, I/NI calls for controlling
the FDR are supplied. In the following subsections,
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Figure 3. Sparse overcomplete representation of allele A and B probes.
The smooth scatter plot for a HapMap Affymetrix 250K_NSP array
sample (CEU_NA12878, G/A allele probes). The three clouds going
outwards from the origin correspond to genotypes AA (upper left
cloud), AB (middle cloud), and BB (lower right cloud). For the
genotype AA, allele A probes show a strong signal and allele B
probes shows a weak signal due to cross-hybridization (analog for
genotype BB). Note, that the middle cloud is closer to the left cloud
than to the right (violating CRMA’s ACC assumptions). The lines are
the estimates of sparse overcomplete representation. They are used to
correct for cross-hybridization by moving the left cloud to be vertical,
the middle cloud to be at the 45  line and the lower right cloud to be
horizontal.
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and are novel in the CNV detection pipeline.
Sparse overcomplete representation
At the pipeline’s step (i), the normalization, cn.FARMS
corrects for cross-hybridization between allele A and allele
B probes. We generalize the ACC method of CRMA.
ACC performs a cone ﬁtting in the 2D space of the
allele A and allele B intensity, where cone borders lay at
the AA and BB genotype (see left and right line in
Figure 3). For each array, the probes are ﬁrst divided
into the allele groups A/T, A/C, A/G, T/C, T/G, C/G to
each of which a cone is separately ﬁtted. ACC assumes
that cross-hybridization for the AB genotype has the
same characteristics as for AA and BB genotypes.
Consequently, the AB genotype regression line is
supposed to be exactly between the AA and BB
genotype regression line (the cone borders), that is the
AB regression line divides the cone into two equal
halves. However, the assumption on the AB genotype re-
gression line is not always true as shown in Figure 3 for a
HapMap Affymetrix 500K array sample. In this example,
the AB regression line does not divide the cone into two
equal halves, which indicates that cross-hybridization is
different for the AB genotype. For the AB genotype,
target fragments for both alleles are present and
compete for hybridization at the probe’s spots.
Motivated by such examples, at the ACC step we not
only estimate a regression line for the AA and BB
genotype but also for the AB genotype. After correction
for cross-hybridization, the AA and BB genotypes should
lay on the x-axis (allele A) and y-axis (allele B), respect-
ively, because one probe allele is supposed to be zero,
while the AB genotype should be on the 45  line. This
problem of ﬁtting three lines in a 2D space is solved in
the ﬁeld of machine learning by sparse overcomplete rep-
resentation (34,35). Data points are described by more
vectors than the dimension of the space, therefore the
description of a data point is not unique. Sparse
overcomplete representations choose the most sparse one
from the set of all possible data descriptions. A sparse
description is appropriate if each data point is mainly
determined by few describing vectors. For allele correc-
tion, the sparse description is justiﬁed because a data
point which is given by the two allele probe intensities
can be described by (i) its angle given by the genotype
(AA, AB and BB–the genotype determines three main
directions) and (ii) its radius given by the copy number.
Thus, we represent the 2D vector of allele A and allele B
probe intensity by a 3D vector where the components cor-
respond to the genotypes AA, AB and BB. The solution of
a sparse overcomplete representation is shown as the lines
in Figure 3. A sparse overcomplete representation of 2D
data xs 2 R
2 can be modeled as:
xs ¼  s zs þ  s ð1Þ
where zs 2 R
3,  s 2 R
2 3 and es  N (0, )s). Here
N(0, )s) is the 2D Gaussian distribution with mean
vector 02R
2 and covariance matrix )s2R
2 2.
Sparseness is enforced by assuming a Laplacian prior
for zs:
p zs ðÞ¼2 ðÞ
 3
2
Y 3
l¼1
exp
ﬃﬃﬃ
2
p
jzslj
  
: ð2Þ
Because the likelihood for this model is analytically in-
tractable, we employ a variational approach according
to Girolami (36). The Laplacian prior is locally
approximated from below by a local Gaussian at the
mode of the Laplacian. An expectation–maximization
algorithm (37) is used to optimize the parameters js and
)s. Using these parameters, the maximum of the zs-pos-
terior ^ zs allows back-transforming the data to ^ xs by
^ xs ¼  s^ zs.
FARMS algorithm
Overview. The main idea of the FARMS algorithm is to
detect a common hidden cause in the measurements
assuming independent noise. The probabilistic FARMS
model:
. regards that probes measuring the same target
(fragment or region) can only be positively correlated,
. estimates (meta-)probe-speciﬁc characteristics,
. automatically trades off signal against noise via the
z-posterior distribution,
. can adjust the signal/noise tradeoff via the priors on
the parameters and
. supplies I/NI calls (32,33).
The I/NI call measures the information gain of the pos-
terior over the prior which can be interpreted as the
negative log signal-to-noise ratio. High data information
content leads to a low variance of the latent variable’s
posterior and a high conﬁdence in the copy number
estimate. The original FARMS applied to 30 real-life ex-
pression data sets could exclude 70–99% of all probe sets
because of their low information content while never
excluding a gene that was known to be biologically mean-
ingful (32). We want to introduce this I/NI call property
into the ﬁeld of CNV analysis to control the FDR.
Brief review. The vector of n probes x is modeled by
probe-effects j and a factor z (latent variable or signal)
representing the raw normalized copy number as:
x ¼   z þ  ; ð3Þ
where x, j2R
n and z  N (0, 1), e  N (0, )). Here
)2R
n n is the diagonal noise covariance matrix to
address independent measurement noise. e and z are
assumed to be statistically independent. Given these as-
sumptions, x is distributed according to the following
Gaussian:
x  N0 ; kkT þ )
  
: ð4Þ
The covariance matrix of x is decomposed into signal jj
T
and noise ). Because ) is diagonal, probe correlations are
attributed to the signal z via j. That means highly
correlated probes lead to large j which in turn leads to
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x is mainly explained by j.
Higher intensity of the probes means more copies and
vice versa, therefore noise-free probes must be positively
correlated. FARMS ensures the positive correlation of
probes by a prior on j which enforces only positive
values: pð Þ¼
Qn
j¼1 pð jÞ, where the rectiﬁed Gaussian
p( j) is given by
 j ¼ maxfyj;0g with yj  N  ;    ðÞ : ð5Þ
Further, the prior on j prefers small values and, there-
fore, model selection tends to explain variation by noise
instead by a signal. Using m  and s , the prior’s inﬂuence
on model selection and, therefore, the signal/noise
tradeoff can be adjusted. FARMS selects the model par-
ameters j and ) by an expectation–maximization algo-
rithm (37) that maximizes the parameter posterior. To
ensure data consistency, negative entries in the data co-
variance matrix are set to zero.
I/NI calls. The I/NI call measures the information gain of
the posterior hidden variable distribution compared to its
prior distribution where the latter represents the null hy-
pothesis. Therefore, the I/NI call measures the tendency to
reject the null hypothesis based on the observed data.
From the model Equation (4) and the Gaussian z-prior
N(0, 1), we can compute the z-posterior p(z | x)a s
z j x  N zjx ;  2
zjx
  
 zjx ¼ x ðÞ
T )
 1  1 þ  T)
 1 
    1
 2
zjx ¼ 1 þ  T) 1 
    1
:
ð6Þ
We see that large j (going with low noise )) leads to low
variance of z | x, which means a precise conditional z.
The variance of z is decomposed into a signal and a
noise part:
varðzÞ¼
1
N
X N
i¼1
Ezijxi z2
i
  
¼
1
N
X N
i¼1
 2
zijxi þ  2
zjx; ð7Þ
where the noise part  2
zjx is independent of xi according to
Equation (6) and serves as I/NI call in FARMS (32).
At the same time  logsz|x measures the information
gain between the prior and the posterior because the
prior has unit variance and therefore zero entropy.
cn.FARMS: I/NI calls and FDR control
As the FARMS I/NI call also cn.FARMS’ I/NI call
measures the information gain of the posterior hidden
variable distribution compared to its prior distribution
that represents the null hypothesis. The variance across
samples of the signal part of maximum posterior hidden
variable z given the observation x is cn.FARMS I/NI call.
This signal variance is zero for the prior. In contrast to
FARMS I/NI call, cn.FARMS I/NI call also includes the
signal strength. This reﬂects the assumption that data
from null hypotheses produce only spurious signals that
are low. Such spurious signals are more likely to be
observed for cn.FARMS at multi-loci modeling with few
metaprobes than for FARMS on expression arrays with
larger probe sets.
First, we compute the signal strength S. The data {xi}
has been probewise standardized to variance 1 and mean
zero, where std(x
raw) is the probes’ SD vector of the raw
data x
raw. We reintroduce the signal strength S as the
median of j scaled by std x
r:
S ¼ median     stdðxrawÞ ðÞ ; ð8Þ
where ‘ ’ is the element-wise product.
Second, we extract the variance of the maximum a pos-
terior hidden variable z given the observation x:
sigvarðzÞ¼
1
N
X N
i¼1
 2
zijxi
¼  T)
 1 covar x ðÞ )
 1  1 þ  T)
 1 
    2
;
ð9Þ
which is between 0 (no signal, only noise) and 1 (only
signal, no noise). Note, that sigvar(z) is one minus
FARMS’ I/NI call squared and corresponds to the part
of the variance in the data explained by the signal.
cn.FARMS’ I/NI call is signal variance multiplied by
the signal strength squared:
I=NI ¼ sigvarðzÞ S2: ð10Þ
Note, that I/NI calls allow comparing two data sets
with respect to common CNVs. In this case, the model
is selected on one data set {xi} and the calls are made on
the other data set {yi} using covar(y).
The I/NI call value considers both the signal strength
and the information gain. If the true copy numbers vary,
then probe intensities are consistent (correlated) and large
(high signal-to-noise-ratio) and therefore lead to a large j
and a small ) which in turn gives a large sigvar(z) (close
to 1). In contrast to these true positives, false positives
come from random independent Gaussian noise vari-
ations, which are unlikely to produce consistent and
large probe intensities. Thus, the larger the I/NI call, the
less likely it was caused by noise. Consequently, the ratio
of false positives decreases with increasing I/NI call
values. A CNV is detected by an I/NI call value exceeding
a detection threshold, therefore the threshold controls the
FDR. The effect of the detection threshold can be seen in
Figure 5, where precision–recall curves on HapMap SNP
6.0 arrays are shown for cn.FARMS. Note that the pre-
cision is 1 FDR, thus the distance of the curve to the
upper limit gives the FDR. Therefore, the curve shows
the FDR as a function of the threshold where indeed
higher thresholds (more to the left) result in smaller
FDRs. The detection threshold for a desired FDR can
either be estimated at chromosome locations where
CNVs are unlikely or at reference data sets.
RESULTS
We compare the new cn.FARMS algorithm with the two
methods which performed best in other comparative
studies on raw copy number estimation (23), namely the
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(see the ‘Introduction’ section for a brief description of
these and the following methods). In Bengtsson et al.
(23), it was shown that both CRMA and dChip perform
better than CNAG and CNAT . Therefore, these two
methods are not regarded in our experiments. Other
methods like Birdseye do not estimate raw copy
numbers and incorporate segmentation and integer copy
number estimation. The latter methods can still be applied
on the output of cn.FARMS for single-locus or multi-loci
modeling.
Because true copy numbers are in general not known,
we use two benchmark data sets from ‘The International
HapMap Project’ where the sex must be determined by the
raw copy numbers at the X chromosome. (i) We ﬁrst use
the 250K Affymetrix array benchmark data set from
Bengtsson et al. (23). Even if these arrays are outdated,
they allow comparisons to other CNV analysis methods
like CNAT and CNAG investigated in Bengtsson et al.
(23). (ii) Next, this benchmark was upgraded to
Affymetrix SNP 6.0 arrays, to allow further assessment
on recent arrays. (iii) Finally, we assess the FDR at
CNV detection on the HapMap phase 2 data set with
Affymetrix SNP 6.0 arrays. To estimate the FDR, we
deﬁne as true CNVs those which were multiple conﬁrmed
by other techniques and reported in Conrad et al. (38).
250K array benchmark
The ﬁrst data set is from Bengtsson et al. (23). It comprises
the 90 CEU founders (30 triplets of father, mother, child)
from ‘The International HapMap Project’ (phase 2) where
the children are removed to avoid biases due to inherited
CNVs. For these 60 CEU founders, their DNA has been
analyzed by Affymetrix Mapping250K_NSP arrays.
Female NA12145 had too low copy number level on
chromosome X and has been excluded (23) which leads
to the ﬁnal data set of 59 CEU founders. The X chromo-
some serves as ground truth to assess the performance of
CNV detection methods because there males possess one
copy and females two. At every location on the X chromo-
some, raw fragment copy numbers (single-loci) and raw
region copy numbers (multi-loci) are used to classify the
sex of the person the sample stems from. To allow
multi-loci classiﬁcation for dChip and CRMA_v2,
adjacent raw fragment copy numbers are averaged
within a region to give a raw region copy number.
However, not all locations on the X chromosome can dis-
tinguish the sex based on the copy numbers. At the
pseudo-autosomal regions (PAR1 and PAR2), the copy
numbers of males and females match. Besides PAR1 and
PAR2, there are segmental duplications on chromosome
Y which match regions at chromosome X (obtained from
‘Segmental duplication DB’ at http://humanparalogy.gs
.washington.edu/build36/). Further chromosome X has
CNV regions (1,2). All loci in pseudo-autosomal, segmen-
tal duplications in Y and CNV regions are excluded in our
classiﬁcation task. Finally, 5557 single loci on the X
chromosome for distinguishing males from females were
kept which gives 327863 (=59 5557) single loci sex
classiﬁcation tasks. The performance of the methods is
measured by receiver operating characteristic (ROC)
curves. The ROC curve plots the true positive rate (sensi-
tivity) as a function of the false positive rate (1 speciﬁ-
city). Methods with ROC curves at the upper left corner
indicate better performance of the corresponding
method—a method’s ROC curve above another
method’s ROC curve shows that the former method
performs better than the latter. The classiﬁcation results
are shown as ROC curves (A and B) in Figure 4. The ROC
curves are summarized by the area under the ROC (AUC)
in Table 1. Further, we give the false positives (males clas-
siﬁed as females) where the numbers of false positives and
false negatives are equal—that is the false positives in the
largest 161153 (number of true female loci=29 5557)
raw copy numbers. To evaluate the statistical signiﬁcance
of the method’s differences in performance, we use
McNemar’s  
2 test under the null hypothesis that the
compared algorithms should have the same error rate
(39). The results show that cn.FARMS performs signiﬁ-
cantly better than dChip and CRMA_v2 and has much
fewer false discoveries—conﬁrming that cn.FARMS yields
low FDRs.
SNP 6.0 array benchmark
Because the Affymetrix 250K arrays are outdated, we
perform the same benchmark test as in the previous
ABCD
Figure 4. ROC curves for cn.FARMS, CRMA_v2 and dChip at the sex classiﬁcation task for 59 HapMap CEU founders based on the X chromo-
some copy numbers. The panels show (A) single-locus and (B) three-loci modeling of Affymetrix Mapping250K_NSP arrays. While panels show (C)
single-locus and (D) three-loci modeling of Affymetrix SNP 6.0 arrays. ROC curves more at the upper left indicate better performing methods (AUC
values for Affymetrix Mapping250K_NSP and Affymetrix SNP 6.0 are given in Table 1). cn.FARMS performs better than CRMA_v2 and dChip.
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6.0 arrays. The SNP 6.0 data set comprises again the
same 59 CEU founders as for the 250K array
benchmark. Note, in contrast to Affymetrix 250K
arrays, for Affymetrix SNP 6.0 arrays we model single
SNP and CNV loci instead of fragments because for
Affymetrix SNP 6.0 the fragment that is targeted by a
probe is ambiguous as both Sty and Nsp fragments can
hybridize to a probe. We again excluded regions which
are pseudo-autosomal, have segmental duplications or
have been reported as CNV regions and kept 35856
single loci for the classiﬁcation task which sums up to
2115504 (=59 35856) sex classiﬁcation tasks.
ROC curves (C and D) in Figure 4 show the results for
which the AUCs and McNemar signiﬁcance tests are
given in Table 1. Again we report the false positives
(females classiﬁed as males) while equalizing the
numbers of false positives and false negatives. By doing
this, we give the number of false positives in the
largest 1039824 raw copy numbers, which is the number
of true female loci = 29 35856. Again cn.FARMS sig-
niﬁcantly outperforms CRMA_v2 and dChip and has
fewer false discoveries. The absolute improvement in
terms of the AUC values seem to be marginal. However,
for single locus modeling, we obtained P-values of 1.8e-65
and 3.1e-26 by the McNemar test for 250K, even going
down to 1e-1160 and 1e-6949 for SNP 6.0 arrays. Clearly,
these P-values indicate signiﬁcant performance improve-
ment of cn.FARMS over its competitors. For 250K
arrays, cn.FARMS has 8472 false positives and the
second best method (dChip) has 9018, which is about
6.5% more false positives. For SNP 6.0 arrays,
cn.FARMS has 56145 false positives and the second
best method (CRMA) has 68593, which is about
21% more false positives. For 250K arrays and multi-loci
modeling with 4 loci, the number of 49 false posi-
tives almost doubles if we look at the next best method
with 95 false positives. For SNP 6.0 arrays and
multi-loci modeling with 4 loci, the number of 366 false
positives increases by a factor of 3.5 if we look at the next
best method with 1338 false positives.
CNV Detection on HapMap
In this subsection, we want verify that cn.FARMS can
indeed control the FDR. In the previous two subsections,
we classiﬁed male/female based on raw copy numbers at X
chromosome locations. The majority of loci have a CNV
as half of the samples are male with copy number one and
the other half are female with copy number two.
Therefore, false discoveries can only appear at the few
pseudo-autosomal or CNV regions. In CNV association
studies, however, false discoveries are much more likely
because true CNVs are rather rare. Therefore, we deﬁne
rare true CNV regions in this experiment where we use
again ‘The International HapMap Project’ phase 2 data
set with Affymetrix SNP 6.0 arrays. The goal is now to
identify true rare CNV regions with a low FDR.
We deﬁne as ‘true CNV regions’ those regions which
were detected and veriﬁed by different biotechnologies in
Conrad et al. (38). In Conrad et al. (38), ﬁrst, CNV can-
didate regions were identiﬁed by NimbleGen tiling arrays
with 2.1 million long oligonucleotide probes covering the
genome with a median probe spacing of 56 bp. From the
identiﬁed CNVs, random control samples were selected
and successfully veriﬁed by quantitative PCR. The CNV
regions identiﬁed by NimbleGen tiling arrays served to
design CNV-typing Agilent CGH arrays comprising
105000 long oligonucleotide probes. With these Agilent
arrays, 4978 CNVs were detected on 450 HapMap phase
3 samples and then completed by 59 CNV regions from
McCarroll et al. (40). The third platform, Illumina
Inﬁnium genotyping (Human660W), found CNVs of
which 87% were already genotyped by the Agilent CGH
arrays. Almost all CNVs from Conrad et al. (38) were
conﬁrmed by at least two different platforms
(NimbleGen tiling arrays, Agilent CGH or Illumina
Table 1. AUC values for cn.FARMS, CRMA_v2 and dChip at the sex classiﬁcation task for 59 HapMap CEU founders based on the X
chromosome copy numbers measured by Affymetrix 250K and Affymetrix SNP 6.0 arrays
Loci Criteria Affymetrix Mapping250K_NSP Affymetrix SNP 6.0
cn.FARMS CRMA_v2 dChip cn.FARMS CRMA_v2 dChip
1 AUC 0.9852 0.9820 0.9819 0.9838 0.9807 0.9721
FP 8472 9106 9018 56145 68593 77438
p-value – 1.8e-65 3.1e-26 – 1e-1160 1e-6949
2 AUC 0.9983 0.9974 0.9969 0.9983 0.9963 0.9894
FP 1375 1449 1611 9777 11705 18039
p-value – 2.7e-4 2.5e-12 – 1e-317 1e-3713
3 AUC 0.9998 0.9995 0.9992 0.9998 0.9990 0.9953
FP 240 366 440 1573 3462 6625
p-value – 2.6e-38 7.2e-58 – 1e-896 1e-3455
4 AUC 1.0000 0.9999 0.9998 0.9999 0.9995 0.9976
FP 49 95 153 366 1338 2985
p-value – 2.8e-10 1.9e-48 – 1e-594 1e-2023
The ﬁrst column gives the number of combined loci, where ‘1’ means single-locus modeling. The second column gives (i) area under the receiver
operating curve given in Figure 4 (‘AUC’), (ii) false positives (‘FP’ – females are classiﬁed as males) and (iii) the P-value of McNemar’s  
2 test for
difference to the cn.FARMS (‘p-value’). False positives are counted in the lowest 166710 and 1075680 (number of true male loci) raw copy numbers
for Affymetrix 250K and Affymetrix SNP 6.0 arrays, respectively. The last six columns give the values for the according array types and methods,
where signiﬁcant better performance is indicated by boldface numbers. cn.FARMS clearly outperforms CRMA_v2 and dChip.
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selected CNV regions from the 60 CEU HapMap phase
2 samples (CEU trios without children). Finally, we
obtained 2515 true CNV regions as reference for our
experiment.
For detecting CNV regions, cn.FARMS uses its I/NI
calls. However for CRMA_v2 and dChip, we have to
deﬁne a CNV calling criterion. We tested different
criteria of which the variance of the raw copy numbers
on the samples gave the best results. This variance
calling criterion is like I/NI call independent of the test
statistic, thus correction for multiple testing is still valid
(33,41).
Using the true CNVs, we can assess the FDR. Instead
of reporting the FDR for a ﬁxed classiﬁcation threshold,
we present the CNV detection results as precision–recall
curves (PRCs). PRCs plot the precision (which is 1 FDR)
as a function of the true positive rate (recall or sensitivity).
Thus, a PRC that is more in the upper-right hand corner
performs better. A larger y-value of the PRC means a
lower FDR for a given sensitivity. Figure 5 shows the
PRC plots where cn.FARMS has indeed lower FDRs
compared to the other methods. The corresponding
areas under the precision–recall curves are listed in
Table 2. A larger value means that the method has
lower FDR averaged over different given recall values.
We observed that for some chromosomes increasing the
window size also increases the FDR because of the
reduced resolution and an overestimate of CNV regions.
cn.FARMS performed signiﬁcantly better than
CRMA_v2 and dChip. The signiﬁcance was obtained by
a one sample t-test under the hypothesis that the
differences between values of the area under the PRC
for two methods have a mean equal to 0. The Gaussian
assumption of the t-test was veriﬁed beforehand by a
Shapiro–Wilk test. The P-values of the t-test were
smaller than 3.9e-7 for CRMA_v2 and smaller than
7.1e-8 for dChip. Figure 6 shows CNV calling plots
across chromosome 4 for 3-loci and 5-loci regions. The
y-axis gives cn.FARMS’ I/NI call and for both
CRMA_v2 and dChip the raw copy number variance
across samples. Calling values are scaled such that the
maximum is one. Local calling densities are encoded by
blue color shades. True CNVs (reported in 38) are marked
as light-rose bars and calls at these loci by red circles. A
perfect calling method would call all true CNVs (red
circles at 1) and would not call others (dark blue back-
ground at 0). True positives (true CNVs) are better
separated from true negatives by cn.FARMS as the
smaller variance of true negatives, which is indicated by
dark blue density at the bottom. The red arrows, e.g. at
positions 65 or 85Mb in the upper cn.FARMS panel,
indicate veriﬁed CNVs which were detected by one
method, in this case cn.FARMS, but not by both others.
cn.FARMS identiﬁes true CNVs with a lower FDR than
CRMA_v2 and dChip.
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Figure 5. Precision-recall curves (PRCs) on HapMap SNP 6.0 arrays for cn.FARMS, CRMA_v2, and dChip at detecting previously multiple
conﬁrmed CNVs reported in Conrad et al. (38). cn.FARMS detection criteria is the I/NI call, whereas CRMA_v2 and dChip use the variance of
raw copy numbers. A PRC more in the upper-right hand corner indicates better performance. Note, that precision is (1 FDR) thus the FDR is the
distance of the curve to the upper limit. Panels (A–D) give the PRC for chromosome 4, 8, chromosome X and the whole genome for 3 loci. Panels
(E–H) show the same for 5 loci. cn.FARMS (solid green) has a clear advantage over dChip (dashed purple) and CRMA_v2 (dotted blue).
cn.FARMS has a considerable lower FDR compared to the other methods.
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Finally, we give the computation time for cn.FARMS,
dChip and CRMA_v2. The required computation time
can be an important factor for choosing an appropriate
method because for many samples and large arrays (e.g.
Affymetrix SNP 6.0 comprises 6.6 million probes), CNV
analysis can take some hours. Table 3 shows the compu-
tational times for the compared methods. cn.FARMS
requires less time than other methods. cn.FARMS’s low
computational load is due to the fact that FARMS’s
update rules both for single and multi-loci modeling are
based on an EM algorithm which converges in only a few
iterations.
DISCUSSION
Variation across samples versus variation across the
chromosome
cn.FARMS identiﬁes regions in the genome that have
variable copy numbers across samples. If a CNV is
found, it is straightforward to select the samples which
caused the variation. In a next step (not considered
here), integer copy numbers will be assigned by segmenta-
tion methods which ﬁnd deviations along the chromo-
some. Thus, segmentation methods serve as a second
ﬁlter which are able to sort out wrongly detected CNVs
stemming from few high variable (noisy) or outlier
samples. High variable samples inject locally variation
across samples which may be detected by cn.FARMS as
a CNV. However, if segmentation methods scan along a
chromosome of a high variable sample, the local
variation may be considered as being in the range of
copy number two. Concluding, cn.FARMS ﬁnds vari-
ations across samples and segmentation ﬁnds variations
across the chromosome—only locations having variations
in both directions are ﬁnally considered as CNV regions.
Affymetrix Mapping250K_NSP to SNP 6.0 arrays
Affymetrix Mapping250K and 500K arrays contain only
SNP probes which are allele A or allele B, strand or
antistrand, prefect match or mismatch, shifted or not. In
contrast to these arrays, Affymetrix SNP 6.0 arrays have,
besides single CNV probes, for each SNP and allele three
identical probes on one strand. One may think that single
locus modeling is superﬂuous for SNP 6.0 arrays, but we
observed that for SNP loci it still improves the results.
Though the probes are identical, their ﬁxed array
location leads to consistent intensity differences which
are captured by single locus modeling.
cn.FARMS for other platforms
Of course, cn.FARMS is not limited to the Affymetrix
platform and can be applied to other platforms like
Illumina bead arrays or Agilent arrays. The concept
remains the same: do genomically adjacent measurements
agree on copy numbers? If they contain variation, then the
more they agree to each other, the more conﬁdent
cn.FARMS is in its copy number estimates.
Combining array types and platforms
cn.FARMS can integrate a mixture of arrays or a mixture
of platforms if normalization is done carefully to make
Table 2. Area under the PRCs on HapMap SNP 6.0 arrays for cn.FARMS, CRMA_v2, and dChip at detecting previously multiple conﬁrmed
CNVs reported in Conrad et al. (38)
Method Chr Area under the PRC
for combined loci of
Chr Area under the PRC
for combined loci of
Chr Area under the PRC
for combined loci of
Chr Area under the PRC
for combined loci of
3457 3457 3457 3457
cn.FARMS 1 0.20 0.23 0.23 0.25 7 0.16 0.19 0.19 0.22 13 0.22 0.26 0.26 0.26 19 0.17 0.21 0.23 0.26
CRMA_v2 0.16 0.19 0.20 0.23 0.10 0.12 0.13 0.16 0.10 0.14 0.18 0.23 0.11 0.13 0.15 0.19
dChip 0.14 0.18 0.19 0.22 0.09 0.11 0.12 0.15 0.08 0.11 0.16 0.20 0.09 0.11 0.13 0.16
cn.FARMS 2 0.19 0.21 0.22 0.25 8 0.27 0.28 0.29 0.27 14 0.06 0.06 0.06 0.06 20 0.24 0.26 0.25 0.31
CRMA_v2 0.12 0.14 0.16 0.21 0.18 0.20 0.22 0.26 0.06 0.06 0.06 0.07 0.12 0.18 0.19 0.25
dChip 0.10 0.13 0.15 0.20 0.13 0.16 0.19 0.21 0.05 0.06 0.06 0.06 0.11 0.14 0.15 0.21
cn.FARMS 3 0.27 0.31 0.34 0.39 9 0.14 0.13 0.12 0.12 15 0.11 0.12 0.14 0.16 21 0.05 0.11 0.12 0.19
CRMA_v2 0.16 0.20 0.23 0.29 0.09 0.08 0.10 0.09 0.07 0.09 0.11 0.14 0.04 0.05 0.10 0.10
dChip 0.13 0.16 0.20 0.25 0.06 0.07 0.07 0.07 0.06 0.08 0.09 0.12 0.03 0.04 0.06 0.07
cn.FARMS 4 0.25 0.30 0.31 0.34 10 0.14 0.17 0.20 0.23 16 0.21 0.31 0.36 0.35 22 0.54 0.61 0.64 0.70
CRMA_v2 0.16 0.20 0.22 0.26 0.09 0.12 0.15 0.19 0.14 0.21 0.25 0.33 0.41 0.50 0.54 0.62
dChip 0.12 0.16 0.19 0.21 0.08 0.11 0.15 0.18 0.12 0.19 0.23 0.32 0.37 0.44 0.49 0.58
cn.FARMS 5 0.19 0.22 0.22 0.24 11 0.24 0.25 0.25 0.27 17 0.17 0.22 0.22 0.26 X 0.99 0.99 0.99 0.99
CRMA_v2 0.11 0.15 0.17 0.21 0.14 0.16 0.19 0.24 0.16 0.22 0.22 0.26 0.99 0.99 0.99 0.99
dChip 0.09 0.11 0.13 0.16 0.08 0.11 0.15 0.19 0.14 0.20 0.21 0.26 0.99 0.99 0.99 0.99
cn.FARMS 6 0.23 0.25 0.25 0.27 12 0.26 0.32 0.33 0.38 18 0.11 0.14 0.15 0.16 all 0.20 0.22 0.24 0.26
CRMA_v2 0.16 0.20 0.22 0.25 0.16 0.22 0.25 0.30 0.05 0.06 0.10 0.11 0.13 0.16 0.18 0.21
dChip 0.13 0.16 0.20 0.23 0.12 0.17 0.21 0.26 0.03 0.04 0.05 0.08 0.11 0.14 0.16 0.19
A larger value means that the method has lower FDR averaged over different given recall values. ‘Chr’ gives the chromosome; ‘Area under the PRC
for combined loci of’ reports the area under the PRCs for different number of combined loci. Note, that large windows can increase the FDR again
because CNV regions are overestimated. cn.FARMS clearly outperforms the other methods.
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the Affymetrix 500K where the metaprobes for one set are
from both the 250K_NSP and the 250K_STY array.
Metaprobe sets can in principle consist of metaprobes
from different platforms like from Affymetrix and
Illumina. The combination of meta-probes across array
types or platforms has the advantage that it increases
the resolution and coverage, but, on the other hand, it
may introduce between array type or between platform
variations. It may even be possible to combine array
metaprobes with metaprobes obtained from next-
generation sequencing (NGS). To provide these NGS
metaprobes, we currently work on adapting the idea of
cn.FARMS to NGS data by a mixture of Poissons model.
A
B
Figure 6. (A) CNV calling plots across chromosome 4 for 3 loci regions (each point in the plot summarizes 3 loci). The y-axis gives the I/NI call
estimated by cn.FARMS and for both CRMA_v2 and dChip it gives the variance. Calling values are scaled such that the maximum is one.
Local calling densities are encode by blue color shades. True CNVs [reported in Conrad et al. (38)] are marked as light rose bars and calls
at these loci by red circles. A perfect calling method would call all true CNVs (red circles at 1) and does not call others (dark blue background at 0).
cn.FARMS separates called true positives (true CNVs) from true negatives better than other methods which can be seen at less variance in
true negatives indicated by dark blue density at the bottom. The red arrows, e.g. at positions 65 or 85Mb in the upper cn.FARMS panel,
indicate veriﬁed CNVs which were detected by one method, in this case cn.FARMS, but not by both others. cn.FARMS identiﬁes true CNVs
with a lower FDR than CRMA_v2 and dChip. (B) The same plot for 5 loci (each point in the plot summarizes 5 loci). The FDR is further reduced,
as can be seen by the lower variance of non-call values at the bottom. Again, cn.FARMS identiﬁes true CNVs with a lower FDR than CRMA_v2
and dChip.
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We introduced a novel method for detecting CNVs called
‘cn.FARMS’ which controls the FDR. In experiments,
cn.FARMS outperformed its competitors both with
respect to FDR and sensitivity, i.e. has fewer false posi-
tives while detecting more true CNVs. The reduced FDR
increases the discovery power of studies and avoids that
researchers are misguided by spurious correlations
between CNVs and diseases.
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